Follow-Up of Study Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer or Other Immunotherapeutic Agents
This protocol aims to provide long-term follow-up and continued use of research specimens of
patients previously enrolled on gene transfer or other immunotherapy studies at the National
Cancer Institute. Subjects will undergo an annual health history for up to 15 years.
James L Gulley, M.D.
National Cancer Institute (NCI)
United States: Federal Government
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|